Parallel Advisors LLC Has $21.03 Million Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Parallel Advisors LLC boosted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRGFree Report) by 10.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 40,283 shares of the medical equipment provider’s stock after purchasing an additional 3,914 shares during the period. Parallel Advisors LLC’s holdings in Intuitive Surgical were worth $21,026,000 at the end of the most recent reporting period.

Other large investors have also bought and sold shares of the company. Bennett Selby Investments LP increased its stake in shares of Intuitive Surgical by 3.9% in the fourth quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider’s stock valued at $234,000 after buying an additional 17 shares during the period. Onefund LLC increased its position in Intuitive Surgical by 1.9% during the 4th quarter. Onefund LLC now owns 947 shares of the medical equipment provider’s stock valued at $494,000 after purchasing an additional 18 shares during the period. LVW Advisors LLC raised its holdings in Intuitive Surgical by 1.3% during the 4th quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider’s stock worth $756,000 after purchasing an additional 19 shares during the last quarter. Wesbanco Bank Inc. lifted its position in shares of Intuitive Surgical by 1.6% in the 4th quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider’s stock worth $635,000 after purchasing an additional 19 shares during the period. Finally, FSM Wealth Advisors LLC boosted its stake in shares of Intuitive Surgical by 3.7% in the 4th quarter. FSM Wealth Advisors LLC now owns 526 shares of the medical equipment provider’s stock valued at $275,000 after purchasing an additional 19 shares during the last quarter. 83.64% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of brokerages recently weighed in on ISRG. BTIG Research lifted their target price on shares of Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a research note on Tuesday, November 26th. Morgan Stanley raised Intuitive Surgical from an “equal weight” rating to an “overweight” rating and lifted their price objective for the stock from $522.00 to $650.00 in a research report on Monday, December 2nd. Leerink Partners upped their target price on Intuitive Surgical from $490.00 to $548.00 in a research report on Monday, January 27th. Piper Sandler reiterated an “overweight” rating and issued a $670.00 target price (up from $538.00) on shares of Intuitive Surgical in a report on Friday, January 24th. Finally, Evercore ISI increased their price target on Intuitive Surgical from $490.00 to $530.00 in a report on Monday, January 27th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and sixteen have assigned a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $613.10.

View Our Latest Report on Intuitive Surgical

Insider Activity

In other Intuitive Surgical news, Director Amal M. Johnson sold 4,635 shares of the company’s stock in a transaction dated Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total value of $2,626,191.00. Following the completion of the sale, the director now directly owns 12,275 shares of the company’s stock, valued at approximately $6,955,015. This represents a 27.41 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CFO Jamie Samath sold 94 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total transaction of $53,684.34. Following the transaction, the chief financial officer now directly owns 2,630 shares in the company, valued at approximately $1,502,019.30. This represents a 3.45 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 33,754 shares of company stock worth $17,691,621 over the last quarter. Insiders own 0.90% of the company’s stock.

Intuitive Surgical Trading Up 1.6 %

Shares of NASDAQ:ISRG opened at $484.44 on Monday. The stock has a market cap of $172.55 billion, a PE ratio of 75.58, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43. The stock’s fifty day simple moving average is $567.46 and its two-hundred day simple moving average is $531.94. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00.

Intuitive Surgical Profile

(Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Featured Articles

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRGFree Report).

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.